Uterine Cancer Study Act of 2025

This bill mandates a study by the U.S. Department of Health and Human Services, in coordination with the FDA and NIH, to examine the potential link between chemical hair straighteners and uterine cancer, with specific focus on higher incidence rates among women of color. The study will review existing research, analyze impacts across racial groups, break down results by product types (like dyed or bleached straighteners), and assess whether the FDA should require additional safety testing for these products. It directly affects women, particularly women of color, who may face elevated risks from hair straightening products. The study must begin within 180 days of enactment and conclude with a report to Congress within two years.